Sichuan, China

Xiaohong Chen

This inventor holds 1 USPTO granted patent. Top assignee: Chengdu Huitai Biomedicine Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaohong Chen. Retrieved from https://idiyas.com/inventor/xiaohong-chen-ddi5u5h7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Xiaohong Chen in Biomedicine

Introduction

Xiaohong Chen is a prominent inventor based in Sichuan, China. He has made significant contributions to the field of biomedicine, particularly in the development of polypeptides and their applications in drug preparation.

Latest Patents

Xiaohong Chen holds a patent for a polypeptide, polypeptide fragment, and derivatives thereof. This invention focuses on the applications of these derivatives in the prevention and treatment of fibrosis diseases. His innovative approach has the potential to impact therapeutic strategies significantly.

Career Highlights

Xiaohong Chen is associated with Chengdu Huitai Biomedicine Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving health outcomes through innovative biomedicine solutions.

Collaborations

Some of his notable coworkers include Wen Yu and De Wei, who contribute to the collaborative efforts in their research projects.

Conclusion

Xiaohong Chen's contributions to biomedicine through his patent and collaborative work highlight his role as an influential inventor in the field. His innovations pave the way for advancements in treating fibrosis diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…